Evidence map›Paper›PMID 41809214›Full record

ReviewWorld journal of gastrointestinal pharmacology and therapeutics2026

Updated review of Janus kinase inhibitors for the management of inflammatory bowel disease.

Sayan Malakar, Suprabhat Giri, Anuraag Jena, Preetam Nath

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of gastrointestinal pharmacology and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sayan MalakarDepartment of Gastroenterology, King George Medical University, Lucknow 226003, Uttar Pradesh, India.
Suprabhat GiriDepartment of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Bhubaneswar 751024, Odisha, India. supg19167@gmail.com.
Anuraag JenaDepartment of Gastroenterology, IMS and SUM Hospital, Bhubaneshwar 751029, Odisha, India.
Preetam NathDepartment of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Bhubaneswar 751024, Odisha, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) management has evolved with the advent of Janus kinase inhibitors (JAKi), oral small molecules that modulate cytokine-driven inflammation

Indexed as

Crohn’s diseaseInflammatory bowel diseaseJanus kinase inhibitorsUlcerative colitis

Identifiers

PMID41809214
PMCPMC12968629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.